Evidence map›Paper›PMID 31677092›Full record

ArticleTranslational stroke research2020

Texture Features of Magnetic Resonance Images: an Early Marker of Post-stroke Cognitive Impairment.

Nacim Betrouni, Moussaoui Yasmina, Stéphanie Bombois, Maud Pétrault, Thibaut Dondaine, Cédrick Lachaud, Charlotte Laloux, Anne-Marie Mendyk, Hilde Henon, Régis Bordet

Abstract read
PubMed Publisher
In one paragraph

Article in Translational stroke research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Nacim BetrouniLaboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France. nacim.betrouni@inserm.fr.ORCID http://orcid.org/0000-0003-1086-5502
Moussaoui YasminaLaboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France.
Stéphanie BomboisLaboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France.
Maud PétraultLaboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France.
Thibaut DondaineLaboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France.
Cédrick LachaudLaboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France.
Charlotte LalouxLaboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France.
Anne-Marie MendykLaboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France.
Hilde HenonLaboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France.
Régis BordetLaboratoire de Pharmacologie, Faculté de Médecine, University of Lille, INSERM, CHU Lille, U1171, Degenerative & Vascular Cognitive Disorders, 1, Place de Verdun, 59000, Lille, France.
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is frequently associated with delayed, long-term cognitive impairment (CI) and dementia. Recent research has focused on identifying early predictive markers of CI occurrence. We carried out a texture analysis of magnetic resonance (MR) images to identify predictive markers of CI occurrence based on a combination of preclinical and clinical data. Seventy-two-hour post-stroke T1W MR images of 160 consecutive patients were examined, including 75 patients with confirmed CI at the 6-month post-stroke neuropsychological examination. Texture features were measured in the hippocampus and entorhinal cortex and compared between patients with CI and those without. A correlation study determined their association with MoCA and MMSE clinical scores. Significant features were then combined with the classical prognostic factors, age and gender, to build a machine learning algorithm as a predictive model for CI occurrence. A middle cerebral artery transient occlusion model was used. Texture features were compared in the hippocampus of sham and lesioned rats and were correlated with histologically assessed neural loss. In clinical studies, two texture features, kurtosis and inverse difference moment, differed significantly between patients with and without CI and were significantly correlated with MoCA and MMSE scores. The prediction model had an accuracy of 88 ± 3%. The preclinical model revealed a significant correlation between texture features and neural density in the hippocampus contralateral to the ischemic area. These preliminary results suggest that texture features of MR images are representative of neural alteration and could be a part of a screening strategy for the early prediction of post-stroke CI.

Indexed as

Magnetic Resonance ImagingAgedAnimalsBiomarkersCognitive DysfunctionDisease Models, AnimalEntorhinal CortexFemaleHippocampusHumansMaleMiddle AgedNeuronsNeuropsychological TestsRats, WistarStrokeBiomarkersCognitive impairmentNeuron lossPredictive featuresRadiomicsStrokeTexture analysis

Identifiers

PMID31677092
OpenAlexW2986326059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.